This is a Notice of Intent, not a request for proposal. The NIH Clinical Center intends to negotiate on a non-competitive basis with Illumina, Inc. to purchase two Illumina MiSeq i100 series instruments for the NIH HLA Laboratory. The instruments will support high-resolution HLA typing for transplant protocols and replace existing MiSeq instruments before the vendor discontinues service on the current model. The total dollar value for this order is $139,100.52. Responsible sources that can provide the required instruments may submit capability statements for Government consideration.